Oaktree Acquisition Corp . (NYSE:OAC), a publicly traded SPAC, today announced the approval of the proposed business combination with Hims & Hers , Inc. New entity will start trading under a new stock ticker (HIMS) on Thursday, January 21st, but you can buy it now during pre-IPO period if you think high gross margin business ..read more

Social Capital Hedosophia (NYSE:IPOC) announced today at a special meeting of its stockholders, that the Company’s stock holders voted to approve the adoption of the previously announced merger deal with Clover Health. This deal rates Clover Health at an enterprise value of about $3.7 billion. Social Capital Hedosophia Holdings Corp. III. is a special purpose acquisition company ..read more

Yesterday we learned that the British drug regulator has granted emergency approval for Pfizer/Biontech COVID-19 vaccine. On the same day the American company Pfizer (NYSE:PFE) and its German partner BioNTech (NASDAQ:BNTX) submitted the necessary documentation for the registration of their corona vaccine in Serbia, according to local media. This was agreed at the meeting of ..read more

Moderna’s (NASDAQ:MRNA) stock recent fall raises the question of whether some pharma stocks have gotten ahead of themselves. And strictly on a price-to-earnings basis, that might look to be the case. But most of these bio-tech companies don’t seem quite so pricey based on another measure, their price-to-earnings growth, or PEG, ratios. Because of the ..read more

The Mainz biotech company BioNTech and the US partner Pfizer (NYSE:PFE) have received the first approval for their corona vaccine. According to the company, the British drug regulator has granted emergency approval. This will give the British the green light earlier than the EU and the US. The U.K. has previously signed an agreement to ..read more

XpresSpa (NASDAQ:XSPA) stock has shed almost 20% in the previous month, but things may change for the better. According to Hawaii News Now, incoming trans-Pacific travelers will need to have a negative COVID-19 test result in hand before departure for Hawaii if they want to bypass quarantine. Travelers must take their COVID-19 test no more ..read more

Moderna Inc (NASDAQ:MRNA) stock is going places on Monday after news related to its corinavirus vaccine appeared in a SEC report. With the US pharmaceutical company Moderna, another manufacturer has submitted relevant data for its corona vaccine. The RNA vaccine has an effectiveness of 94.5 percent, which is much better than previously disclosed result by ..read more

A huge breakthrough in the fight against the COVID pandemic seems to be rolling on the horizon. BioNTech (BNTX) and Pfizer (PFE) have announced that the long-awaited corona vaccine is 90 percent effective. Experts had assumed a significantly lower effectiveness. The BioNTech share reacted with a plus of 25 percent during pre-market session while PFE ..read more

CureVac (NASDAQ:CVAC) stock price is going up again, this time on phase 2 news. German based company has started the second phase of testing its vaccine candidate. The first participant in the phase 2a study had been vaccinated, it is announced Tuesday evening. The study is running in Peru and Panama with 690 healthy participants ..read more

On June 18, 2020, Ultragenyx Pharmaceutical (NASDAQ: RARE) and Kyowa Kirin Co., Ltd. issued a joint announcement that the U.S. FDA has approved Crysvita® (burosumab) for the treatment of fibroblast growth factor 23 (FGF23)-related hypophosphatemia in tumor-induced osteomalacia (TIO) associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized in adults and pediatric ..read more